Table of Contents Table of Contents
Previous Page  756 / 1068 Next Page
Information
Show Menu
Previous Page 756 / 1068 Next Page
Page Background

R

A

N

D

SCPRT

5X5 GY

N = 885 patients

RAPIDO Trial

CapOx + 6

Capecitabine:

825 mg/m2

T4

T

M

O

M

I

Z

A

T

I

O

N

Standard

CRT 50.4Gy

Oxaliplatin:

130 mg/m2

EMVI+

N2

CRM+

E

Primary endpoint 3 year DFS